Clinical Trial Update: Endotype DIrected Treatment for OSA in Down Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is recruiting to evaluate endotype-directed treatment for obstructive sleep apnea in individuals with Down syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome
• Obstructive Sleep Apnea

Snippet

Sponsor: University of Arizona | Conditions: Obstructive Sleep Apnea (OSA), Down Syndrome | Phase 4 | Status: RECRUITING